Correlation between hyperuricemia and all-cause mortality in patients with rheumatoid arthritis
CSTR:
Author:
Affiliation:

(1.Department of Rheumatology and Immunology, Affiliated Huai′an First People′s Hospital of Nanjing Medical University, Huaian 223300, Jiangsu Province, China;2.Department of Rheumatology and Immunology, Jiangsu Provincial Hospital, Nanjing 210029, China)

Clc Number:

Fund Project:

This workwassupported by National NaturalScienceFoundationof China(82271844),Science and TechnologyDevelopment Program in Traditional Chinese Medicine of Jiangsu Province(MS2022106);Huai'an Key Laboratory of AutoimmuneDiseases(HAP202302).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To investigate the correlation between hyperuricemia (HUA)and all-cause mortality in rheumatoid arthritis (RA) patients. Methods Based on data from the 2001 to 2018 National Health and Nutritional Examination Survey (NHANES), 1 507 RA patients at baseline were enrolled. According to survival status at follow-up endpoint, participants were divided into a survival group (n=1 035) and a death group (n=472). They were further divided into a hyperuricemia (HUA) group (n=418) and a non-HUA group (n=1 089) based on HUA comorbidity. Statistical analysis was conducted using R software (version 4.1.0). Restricted cubic spline (RCS) models, multivariable Cox proportional hazards regression, and Kaplan-Meier survival analysis were employed to assess the relationship between HUA and all-cause mortality in RA patients. Subgroup analyses were conducted according to age and sex. Results There were statistically significant differences between the two groups in age, race, family annual income, marital status, education level, and body mass index (all P<0.05). Compared with the survival group, the death group had significantly increased prevalence of hypertension, SUA levels, and urinary albumin levels, but significantly decreased 25 hydroxyvitamin D and urinary creatinine levels, with statistically significant differences (all P<0.05). For every 10 μmol/L increase in SUA in RA patients, the risk of all-cause mortality increased by 1% (HR=1.01,95%CI 1.01-1.02). Sex-stratified analysis showed a significant positive correlation between SUA levels and all-cause mortality in female RA patients (HR=1.02,95%CI 1.01-1.04). Age-stratified analysis showed that for RA patients aged ≥ 60 years, an increase of 10 μmol/L in SUA levels raised the risk of all-cause mortality by 1% (HR=1.01,95% CI 1.00-1.03), and that female RA patients aged ≥ 60 years had a strong association, with an increase of 10 μmol/L in SUA levels raising the risk of all-cause mortality by 2% (HR=1.02,95%CI 1.01-1.04). The mortality risk of patients in the HUA group was 33% higher than that in the non-HUA group (HR=1.33,95%CI 1.08-1.62). Sex-stratified analysis showed that the mortality risk of female patients in the HUA group increased by 69% (HR=1.69,95%CI 1.23-2.33). Age-stratified analysis showed that patients aged ≥ 60 years in the HUA group had a 39% increased risk of mortality (HR=1.39,95%CI 1.12-1.73), with the most significant increase in risk observed in the subgroup of females aged ≥ 60 years (HR=1.76,95%CI 1.26-2.45). Kaplan Meier survival analysis showed that HUA may be associated with lower survival rates, and cumulative mortality was significantly higher in the HUA group than in the non-HUA group (P<0.05). RCS analysis showed that a non-linear positive correlation between SUA levels and all-cause mortality when SUA>350.9 μmol/L among all RA patients (P=0.017) and when SUA>333.1 μmol/L in female RA patients aged ≥ 60 years (P=0.004). Conclusion HUA is significantly associated with increased all-cause mortality risk in RA patients, particularly affecting elderly female populations. Closer monitoring is recommended for elderly female RA patients with higher SUA levels (≥333.1 μmol/L).

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:September 22,2024
  • Revised:
  • Adopted:
  • Online: September 22,2025
  • Published:
Article QR Code